The RNA mimic that Dr. Zachary Campbell’s team designed showed the ability to reduce behavioral response to pain.
For anyone who has accidentally injured themselves, Dr. Zachary Campbell not only sympathizes, he’s developing new ways to blunt pain.
“If you have ever hit yourself with a hammer, afterward, even a light touch can be painful for days or even weeks,” said Campbell, who researches pain on the molecular level at The University of Texas at Dallas. “While many of us may not be coordinated enough to avoid an accident, my goal is to disrupt the inception and persistence of pain memories.”
Campbell directs the Laboratory of RNA Control and recently published a study in the journal Nature Communications in close collaboration with Dr. Ted Price, an associate professor from the Pain Neurobiology Research Group, and Dr. Michael Burton, a new assistant professor from the School of Behavioral and Brain Sciences who conducted postdoctoral work at UT Dallas.
This work describes a new method of reducing pain-associated behaviors with RNA-based medicine, creating a new class of decoy molecules that prevent the onset of pain.
“Even simple memories are nothing short of extraordinary,” Campbell said. “To promote healing, our nervous system catalogs our sensory experiences and, under normal circumstances, eventually forgets. Defects in this process can result in chronic pain — a root cause of enormous suffering.”
Reducing Behavioral Response to Pain
The need for research in this field is easy to understand.
“Pain is a pervasive and devastating problem,” Campbell said. “It’s the most prominent reason why Americans seek medical attention. Poorly treated pain causes enormous human suffering, as well as a tremendous burden on medical care systems and our society.”
Campbell’s team took the approach of blocking the creation of the proteins that set pain in motion. After an injury, instructions provided by the genome — the full set of genetic instructions present in each cell — are translated to create pain-signaling proteins. Those instructions are encoded in molecules called messenger RNA, or mRNA. The decoy Campbell’s team constructed interrupts the pain-protein synthesis process that mRNA facilitates, reducing signs of inflammation and impairing pain behaviors.
“When you have an injury, certain molecules are made rapidly,” said Campbell, an assistant professor in the Department of Biological Sciences in the School of Natural Sciences and Mathematics. “With this Achilles’ heel in mind, we set out to sabotage the normal series of events that produce pain at the site of an injury. In essence, we eliminate the potential for a pathological pain state to emerge.”
The RNA mimic that Campbell’s team designed was injected at the site of an injury in experiments on mice, and showed the ability to reduce behavioral response to pain.
“We’re manipulating one step of protein synthesis,” Campbell said. “Our results indicate that local treatment with the decoy can prevent pain and inflammation brought about by a tissue injury.”
Overcoming a Molecular Challenge
One huge hurdle in creating such an RNA-based compound was overcoming the rapid metabolism of these molecules.
“Molecules that degrade quickly in cells are not great drug candidates. The stability of our compounds is an order of magnitude greater than unmodified RNA.” Campbell said.
Campbell explained that specialized nerve cells called nociceptors communicate with your brain in response to thermal, chemical and mechanical stimuli.
“Imagine touching a hot stovetop, walking into a wall or getting a paper cut,” he said. “Part of the cellular origin that causes subsequent pain is initiated by nociceptors, but the molecular mechanisms behind these persistent changes are poorly understood. Our study developed a targeted inhibitor that both shed light on these processes and reduced pain sensitization following an injury.”
“The ongoing opioid crisis highlights the need for pain treatments that don’t create addictions. Hopefully, this is a step in that direction.”
Campbell emphasized the importance of treating pain at the site of an injury; a major problem with drugs that interact with the central nervous system is that they also can affect the reward center of the brain.
“The ongoing opioid crisis highlights the need for pain treatments that don’t create addictions,” he said. “Hopefully, this is a step in that direction.”
Campbell credits the role of team-based science for the discovery.
“This work was made possible through a tight collaboration between my lab and that of Dr. Price,” Campbell said. “These experiments would not have been possible without Ted’s tremendous support, dedication and broadly insightful character. Ted is an eminent scholar at the interface of translational control and pain. His deep expertise in pain mechanisms permeates the manuscript.
“I feel incredibly fortunate to benefit from outstanding collaborators here at UT Dallas, which has emerged as a key player on the national stage of pain research,” said Campbell, who arrived at the University in 2015.
This study was supported by a $2 million, five-year grant from the National Institutes of Health to study RNA-binding proteins in peripheral neurons. Price and Dr. Joseph Pancrazio, a professor in the Department of Bioengineering in the Erik Jonsson School of Engineering and Computer Science, are collaborators on the grant.
Campbell believes this effort proposes a new method of treating a broad range of medical issues.
“To the best of our knowledge, this is the first attempt to create a chemically stabilized mimic to competitively inhibit RNA to disrupt RNA-protein interactions,” he said. “Our approach suggests that targeting those interactions may provide a new source of pharmacological agents. This proof of concept allows us to open a whole new area of science by virtue of the route that we’re attacking it.”
The Latest on: Pain
via Google News
The Latest on: LpPain
- Trump's doctor dismisses speculation of chest pain on November 18, 2019 at 8:31 pm
Donald Trump's doctor on Monday denied reports that the US president had recently suffered chest pain after he attended an unannounced medical checkup in Washington. Trump, 73, spent just over an hour ...
- Donald Trump's doctor dismisses 'speculation' of chest pain on November 18, 2019 at 7:43 pm
Donald Trump's doctor issued a report Monday on the US president's health after a "routine, planned" check-up, saying that contrary to some reports he had not suffered any chest pain. Trump, 73, spent ...
- Why Lady Gaga Sees ‘Pain’ When She Looks At Her Oscar For ‘Shallow’ on November 18, 2019 at 5:45 pm
“When I won the Oscar for “Shallow,” I looked at it, and a reporter asked me, ‘When you look at that Oscar, what do you see?’ And I said, ‘I see a lot of pain.’ And I wasn’t lying in that moment,” she ...
- Neuropathy patient says numbness and pain are gone with advanced treatment on November 18, 2019 at 3:07 pm
HOUSTON — Do you suffer from nerve pain daily? If medications are masking the symptoms and not improving your quality of life, there is hope. A proprietary treatment by Dr. Bao Thai of Advanced Nerve ...
- Bears’ Nagy says Trubisky lifted because of hip pain on November 18, 2019 at 2:08 pm
LAKE FOREST, Ill. (AP) Chicago Bears coach Matt Nagy insisted he pulled Mitchell Trubisky near the end of Sunday’s loss to the Los Angeles Rams because of pain in his right hip and not because he’s ...
- Seeing Palestinian Pain as Art at the Other Israeli Film Festival (Guest Blog) on November 18, 2019 at 10:14 am
As I sit here, writing about Palestinian films and The Other Israeli Film Festival, rockets lobbed from Gaza are falling once again in Israel, wreaking havoc and terror. The rockets do not fall on ...
- Sensible Change Minnesota Seeks Adding Chronic Pain To Conditions OK’d For Medical Marijuana on November 18, 2019 at 10:09 am
MINNEAPOLIS (WCCO) — Medical cannabis could be available to more Minnesotans. A push is underway to have “chronic pain” as a covered condition. Medical cannabis was signed into law in 2014. It covers ...
- In Its First UK Action, PAIN Sackler Holds “Die-in” at the V&A on November 18, 2019 at 9:22 am
A surprise protest organized by PAIN Sackler in the V&A’s Sackler Courtyard (all images by the author for Hyperallergic) LONDON — On Saturday, November 16, activists gathered at London’s Victoria & ...
- Stefanos Tsitsipas prepared for 'pain' to break Big Three's dominance on November 18, 2019 at 5:14 am
Greek tennis star Stefanos Tsitsipas hopes to use his 2019 ATP Finals win as a springboard to breaking the Big Three;s grand slam dominance in 2020. Like us on Facebook to see similar stories Please ...
via Bing News